$PGNX Company News Progenics prices offering a
Post# of 72725
Posted On: 06/23/2014 11:42:05 AM
$PGNX Company News
Progenics prices offering at 5.2% discount 12:02 p.m. Nov. 29, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:15 p.m. July 30, 2012 - MarketWatch
Progenics, Salix shares hit by FDA rejection 11:29 a.m. July 30, 2012 - Val Brickates Kennedy
Progenics, Salix tumble on FDA drug rejection 10:46 a.m. July 30, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:58 p.m. Dec. 20, 2011 - Val Brickates Kennedy
Drug stocks up as OSI rejects $3.5 billion bid 4:32 p.m. March 15, 2010 - Kate Gibson
Wyeth, Progenics: Phase 3 trial of Relistor misses endpoints 7:05 a.m. May 22, 2008 - Michelle Donley
Wyeth, Progenics get Canadian approval for Relistor 7:09 a.m. April 1, 2008 - Michael Kitchen
Monday's biggest gaining and declining stocks 2:07 p.m. March 17, 2008 - MarketWatch
U.S. stocks close lower as record high crude weighs 4:38 p.m. March 12, 2008 - Nick Godt
Drug stocks gain; Progenics plunges on failed study 3:46 p.m. March 12, 2008 - Val Brickates Kennedy
U.S. stock futures steady to lower after big run-up 9:16 a.m. March 12, 2008 - Steve Goldstein
Wyeth delayed on trade errors; Momenta shares slump 1:13 p.m. June 28, 2007 - Val Brickates Kennedy
Progenics, Wyeth report positive methylnaltrexone study 5:10 a.m. June 28, 2007 - Steve Goldstein
Progenics, Wyeth say 'positive' Methylnaltrexone study 5:07 a.m. June 28, 2007 - Steve Goldstein
Biotech, pharma rise; Vertex slips on earnings 12:01 p.m. May 1, 2007 - Val Brickates Kennedy
Progenics, Wyeth submit NDA for methylnaltrexone formula 5:08 a.m. March 30, 2007 - Sarah Turner
Progenics, Wyeth to submit NDA for methylnaltrexone formula 5:01 a.m. March 30, 2007 - Sarah Turner
U.S. markets poised to retest major support 10:14 a.m. March 14, 2007 - Michael Ashbaugh
Biotech, pharma benchmarks fall; CV Therapeutics dives 5:18 p.m. March 7, 2007 - Val Brickates Kennedy
What Does A Positive Adcom Mean For Progenics And Salix? 1:54 p.m. June 17, 2014 - Seeking Alpha
$5 Or Less: 3 Small, Speculative Biotechs On The Move 1:41 p.m. June 17, 2014 - Seeking Alpha
Two Undervalued Biopharmas to Buy Now 10:55 a.m. June 16, 2014 - Barrons.com
Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 9.23% - Tale of the Tape 8:44 a.m. June 13, 2014 - Zacks.com
Progenics schedules conference call to discuss Ad Comm recommendation 6:06 p.m. June 12, 2014 - Seeking Alpha
Ad Comm recommendation bodes well for opioid-induced constipation drugs 12:54 p.m. June 12, 2014 - Seeking Alpha
Progenix trading halted while Ad Comm meets 8:28 a.m. June 11, 2014 - Seeking Alpha
Progenics Pharmaceuticals (PGNX) in Focus: Stock Falls 5.5% - Tale of the Tape 8:49 a.m. June 5, 2014 - Zacks.com
The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming 8:30 a.m. June 2, 2014 - Seeking Alpha
Progenics Pharma Poised For A Potential Price Increase Ahead Of June 11 Adcom 8:30 a.m. May 30, 2014 - Seeking Alpha
2nd Half Of 2014 Biotechnology Catalysts: Part 1 9:34 a.m. May 27, 2014 - Seeking Alpha
Nektar Therapeutics: The Time Is Nigh 11:57 a.m. May 19, 2014 - Seeking Alpha
Progenics' Q1 Loss Narrows - Analyst Blog 11:10 a.m. May 15, 2014 - Zacks.com
Salix Q1 Earnings Boosted by Santarus Acquisition - Analyst Blog 1:41 p.m. May 9, 2014 - Zacks.com
Progenics Pharmaceuticals' (PGNX) CEO Mark Baker on Q1 2014 Results - Earnings Call Transcript 12:31 p.m. May 9, 2014 - Seeking Alpha
10-Q: PROGENICS PHARMACEUTICALS INC 10:42 a.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Progenics Pharmaceuticals (PGNX) Q1 2014 Results - Earnings Call Webcast 8:25 a.m. May 9, 2014 - Seeking Alpha
Progenics Finishes Patient Enrollment - Analyst Blog 7:00 p.m. April 25, 2014 - Zacks.com
Progenics Pharmaceuticals Announces Completion of Enrollment of Chemotherapy Naive Cohort in Phase II Trial of PSMA ADC 9:17 a.m. April 24, 2014 - benzinga.com
EMA considers Relistor label expansion 12:21 p.m. April 23, 2014 - Seeking Alpha
Sales, Clinical Hold Removal, Trial Initiations, and Committee Recommendations - Analyst Notes on Geron, Zalicus, Northwest Biotherapeutics, Progenics and TG Therapeutics 5:30 a.m. June 17, 2014 - PR Newswire - PRF
Progenics Schedules Investor Conference Call Following FDA Advisory Committee 3:41 p.m. June 12, 2014 - GlobeNewswire
FDA Ad Comm Provides Recommendations Regarding the Potential Cardiovascular Risk Associated with the Class of Peripherally-active Opioid Receptor Antagonists and the Trials to Support Approval of Products for OIC 2:32 p.m. June 12, 2014 - BusinessWire - BZX
Progenics Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Consider and Provide Recommendations Regarding Peripherally-Acting Opioid Receptor Antagonists 7:06 a.m. June 11, 2014 - GlobeNewswire
Technical Analysis on Biotech Equities -- Research on Incyte, Progenics Pharma, Immunomedics, and Arqule 7:30 a.m. June 5, 2014 - PR Newswire - PRF
Progenics Pharmaceuticals CEO Mark Baker to Present at Jefferies Global Healthcare Conference 2:31 p.m. June 2, 2014 - GlobeNewswire
Progenics Pharmaceuticals' PSMA ADC Data Selected for Poster Highlight Presentation at ASCO 2014 8:01 a.m. May 30, 2014 - GlobeNewswire
Stocks Analysis on Top Gainers -- Research on Progenics Pharma, Lionbridge Technologies, Nuverra Environmental Solutions, and Senomyx 11:30 a.m. May 12, 2014 - PR Newswire - PRF
Progenics Pharmaceuticals Announces First Quarter 2014 Financial Results 7:31 a.m. May 9, 2014 - GlobeNewswire
Progenics Pharmaceuticals Sets First Quarter 2014 Financial Results Call for May 9 7:31 a.m. May 1, 2014 - GlobeNewswire
Earnings Schedules, Acquisition Agreements, and Financial Results Release - Analyst Notes on Mallinckrodt, BioMarin, Salix Pharmaceuticals, St. Jude Medical and Quest Diagnostics 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Progenics Pharmaceuticals Announces the Completion of Enrollment of Chemotherapy Naive Cohort in Phase II Trial of PSMA ADC 10:18 a.m. April 24, 2014 - GlobeNewswire
Salix Pharmaceuticals and Progenics Pharmaceuticals Announce the Acceptance of Submission to Expand the Use of RELISTOR in Chronic Non-Cancer Pain by the European Medicines Agency 7:02 a.m. April 22, 2014 - BusinessWire - BZX
Progenics Pharmaceuticals and Centre for Probe Development and Commercialization Announce Agreement to Manufacture Targeted Radiotherapeutic Candidate for Ultra-Orphan Indications 12:36 p.m. April 1, 2014 - GlobeNewswire
Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa 8:00 a.m. March 21, 2014 - PR Newswire - PRF
Top Gainers Ahead of Market -- Research on Genco Shipping & Trading, Progenics Pharma, Rambus, and Exact Sciences 8:05 a.m. March 19, 2014 - PR Newswire - PRF
Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2013 Financial Results and Initiates Clinical Development of Small Molecule Targeted Therapeutic 9:02 a.m. March 13, 2014 - GlobeNewswire
Progenics Pharmaceuticals Sets 4Q and Year-End 2013 Financial Results Call for March 13 1:48 p.m. March 10, 2014 - GlobeNewswire
Progenics Pharmaceuticals Sets 1Q 2014 Financial Results Call for March 13 1:00 p.m. March 4, 2014 - GlobeNewswire
DryShips Braces for More Losses in Slowly Recovering Economy 10:34 a.m. Feb. 24, 2014 - ACCESSWIRE
Progenics prices offering at 5.2% discount 12:02 p.m. Nov. 29, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:15 p.m. July 30, 2012 - MarketWatch
Progenics, Salix shares hit by FDA rejection 11:29 a.m. July 30, 2012 - Val Brickates Kennedy
Progenics, Salix tumble on FDA drug rejection 10:46 a.m. July 30, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:58 p.m. Dec. 20, 2011 - Val Brickates Kennedy
Drug stocks up as OSI rejects $3.5 billion bid 4:32 p.m. March 15, 2010 - Kate Gibson
Wyeth, Progenics: Phase 3 trial of Relistor misses endpoints 7:05 a.m. May 22, 2008 - Michelle Donley
Wyeth, Progenics get Canadian approval for Relistor 7:09 a.m. April 1, 2008 - Michael Kitchen
Monday's biggest gaining and declining stocks 2:07 p.m. March 17, 2008 - MarketWatch
U.S. stocks close lower as record high crude weighs 4:38 p.m. March 12, 2008 - Nick Godt
Drug stocks gain; Progenics plunges on failed study 3:46 p.m. March 12, 2008 - Val Brickates Kennedy
U.S. stock futures steady to lower after big run-up 9:16 a.m. March 12, 2008 - Steve Goldstein
Wyeth delayed on trade errors; Momenta shares slump 1:13 p.m. June 28, 2007 - Val Brickates Kennedy
Progenics, Wyeth report positive methylnaltrexone study 5:10 a.m. June 28, 2007 - Steve Goldstein
Progenics, Wyeth say 'positive' Methylnaltrexone study 5:07 a.m. June 28, 2007 - Steve Goldstein
Biotech, pharma rise; Vertex slips on earnings 12:01 p.m. May 1, 2007 - Val Brickates Kennedy
Progenics, Wyeth submit NDA for methylnaltrexone formula 5:08 a.m. March 30, 2007 - Sarah Turner
Progenics, Wyeth to submit NDA for methylnaltrexone formula 5:01 a.m. March 30, 2007 - Sarah Turner
U.S. markets poised to retest major support 10:14 a.m. March 14, 2007 - Michael Ashbaugh
Biotech, pharma benchmarks fall; CV Therapeutics dives 5:18 p.m. March 7, 2007 - Val Brickates Kennedy
What Does A Positive Adcom Mean For Progenics And Salix? 1:54 p.m. June 17, 2014 - Seeking Alpha
$5 Or Less: 3 Small, Speculative Biotechs On The Move 1:41 p.m. June 17, 2014 - Seeking Alpha
Two Undervalued Biopharmas to Buy Now 10:55 a.m. June 16, 2014 - Barrons.com
Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 9.23% - Tale of the Tape 8:44 a.m. June 13, 2014 - Zacks.com
Progenics schedules conference call to discuss Ad Comm recommendation 6:06 p.m. June 12, 2014 - Seeking Alpha
Ad Comm recommendation bodes well for opioid-induced constipation drugs 12:54 p.m. June 12, 2014 - Seeking Alpha
Progenix trading halted while Ad Comm meets 8:28 a.m. June 11, 2014 - Seeking Alpha
Progenics Pharmaceuticals (PGNX) in Focus: Stock Falls 5.5% - Tale of the Tape 8:49 a.m. June 5, 2014 - Zacks.com
The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming 8:30 a.m. June 2, 2014 - Seeking Alpha
Progenics Pharma Poised For A Potential Price Increase Ahead Of June 11 Adcom 8:30 a.m. May 30, 2014 - Seeking Alpha
2nd Half Of 2014 Biotechnology Catalysts: Part 1 9:34 a.m. May 27, 2014 - Seeking Alpha
Nektar Therapeutics: The Time Is Nigh 11:57 a.m. May 19, 2014 - Seeking Alpha
Progenics' Q1 Loss Narrows - Analyst Blog 11:10 a.m. May 15, 2014 - Zacks.com
Salix Q1 Earnings Boosted by Santarus Acquisition - Analyst Blog 1:41 p.m. May 9, 2014 - Zacks.com
Progenics Pharmaceuticals' (PGNX) CEO Mark Baker on Q1 2014 Results - Earnings Call Transcript 12:31 p.m. May 9, 2014 - Seeking Alpha
10-Q: PROGENICS PHARMACEUTICALS INC 10:42 a.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
Progenics Pharmaceuticals (PGNX) Q1 2014 Results - Earnings Call Webcast 8:25 a.m. May 9, 2014 - Seeking Alpha
Progenics Finishes Patient Enrollment - Analyst Blog 7:00 p.m. April 25, 2014 - Zacks.com
Progenics Pharmaceuticals Announces Completion of Enrollment of Chemotherapy Naive Cohort in Phase II Trial of PSMA ADC 9:17 a.m. April 24, 2014 - benzinga.com
EMA considers Relistor label expansion 12:21 p.m. April 23, 2014 - Seeking Alpha
Sales, Clinical Hold Removal, Trial Initiations, and Committee Recommendations - Analyst Notes on Geron, Zalicus, Northwest Biotherapeutics, Progenics and TG Therapeutics 5:30 a.m. June 17, 2014 - PR Newswire - PRF
Progenics Schedules Investor Conference Call Following FDA Advisory Committee 3:41 p.m. June 12, 2014 - GlobeNewswire
FDA Ad Comm Provides Recommendations Regarding the Potential Cardiovascular Risk Associated with the Class of Peripherally-active Opioid Receptor Antagonists and the Trials to Support Approval of Products for OIC 2:32 p.m. June 12, 2014 - BusinessWire - BZX
Progenics Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Consider and Provide Recommendations Regarding Peripherally-Acting Opioid Receptor Antagonists 7:06 a.m. June 11, 2014 - GlobeNewswire
Technical Analysis on Biotech Equities -- Research on Incyte, Progenics Pharma, Immunomedics, and Arqule 7:30 a.m. June 5, 2014 - PR Newswire - PRF
Progenics Pharmaceuticals CEO Mark Baker to Present at Jefferies Global Healthcare Conference 2:31 p.m. June 2, 2014 - GlobeNewswire
Progenics Pharmaceuticals' PSMA ADC Data Selected for Poster Highlight Presentation at ASCO 2014 8:01 a.m. May 30, 2014 - GlobeNewswire
Stocks Analysis on Top Gainers -- Research on Progenics Pharma, Lionbridge Technologies, Nuverra Environmental Solutions, and Senomyx 11:30 a.m. May 12, 2014 - PR Newswire - PRF
Progenics Pharmaceuticals Announces First Quarter 2014 Financial Results 7:31 a.m. May 9, 2014 - GlobeNewswire
Progenics Pharmaceuticals Sets First Quarter 2014 Financial Results Call for May 9 7:31 a.m. May 1, 2014 - GlobeNewswire
Earnings Schedules, Acquisition Agreements, and Financial Results Release - Analyst Notes on Mallinckrodt, BioMarin, Salix Pharmaceuticals, St. Jude Medical and Quest Diagnostics 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Progenics Pharmaceuticals Announces the Completion of Enrollment of Chemotherapy Naive Cohort in Phase II Trial of PSMA ADC 10:18 a.m. April 24, 2014 - GlobeNewswire
Salix Pharmaceuticals and Progenics Pharmaceuticals Announce the Acceptance of Submission to Expand the Use of RELISTOR in Chronic Non-Cancer Pain by the European Medicines Agency 7:02 a.m. April 22, 2014 - BusinessWire - BZX
Progenics Pharmaceuticals and Centre for Probe Development and Commercialization Announce Agreement to Manufacture Targeted Radiotherapeutic Candidate for Ultra-Orphan Indications 12:36 p.m. April 1, 2014 - GlobeNewswire
Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa 8:00 a.m. March 21, 2014 - PR Newswire - PRF
Top Gainers Ahead of Market -- Research on Genco Shipping & Trading, Progenics Pharma, Rambus, and Exact Sciences 8:05 a.m. March 19, 2014 - PR Newswire - PRF
Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2013 Financial Results and Initiates Clinical Development of Small Molecule Targeted Therapeutic 9:02 a.m. March 13, 2014 - GlobeNewswire
Progenics Pharmaceuticals Sets 4Q and Year-End 2013 Financial Results Call for March 13 1:48 p.m. March 10, 2014 - GlobeNewswire
Progenics Pharmaceuticals Sets 1Q 2014 Financial Results Call for March 13 1:00 p.m. March 4, 2014 - GlobeNewswire
DryShips Braces for More Losses in Slowly Recovering Economy 10:34 a.m. Feb. 24, 2014 - ACCESSWIRE
(0)
(0)Scroll down for more posts ▼